Structural and organizational determinants of quality of care in patients with schizophrenia in italy

Journal of Nervous and Mental Disease

Volumn 196, Issue 12, 2008, Pages 923-926

  Bollini, Paola ^a   Pampallona, Sandro ^a   Tibaldi, Giuseppe ^b   Bianco, Maurizio ^c   Nieddu, Salvatore ^d   Munizza, Carmine ^b  

^a Services for Medical Research forMed   (Switzerland)

^b Centro Studi e Ricerche in Psichiatria   (Italy)

^c Faculty of Economics   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Antipsychotic drugs; Quality of care; Schizophrenia

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH ECONOMICS; HUMAN; ITALY; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MENTAL HEALTH CARE; NURSE; PERSONNEL MANAGEMENT; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHIATRIST; SCHIZOPHRENIA; CLINICAL PRACTICE; MENTAL HEALTH SERVICE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; STANDARD; STATISTICS;

ADULT; ANTIPSYCHOTIC AGENTS; GUIDELINE ADHERENCE; HUMANS; ITALY; MENTAL HEALTH SERVICES; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF HEALTH CARE; SCHIZOPHRENIA;

EID: 58149218725     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e31818eea6e     Document Type: Article

References (23)

1. Anthony RN, Young DW (1984) Management control in non-profit organisations. Text and cases. Homewood: Richard D. Irwin.
2. Bollini P, Pampallona S, Nieddu S, Bianco M, Tibaldi G, Munizza C (2008) Indicators of conformance with guidelines of schizophrenia treatment in mental health services. Psychiatr Serv. 59:782-791.
3. Busch AB, Frank RG, Lehman AF (2004) The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia. Arch Gen Psychiatry. 61:442-448.
4. Davis D, Evans M, Jadad A, Perrier L, Rath D, Ryan D, Sibbald G, Straus S, Rappolt R, Wowk M, Zwarenstein M (2003) The case for knowledge translation: Shortening the journey from evidence to effect. BMJ. 327:33-35.
5. Dickey B, Normand SL, Eisen S, Hermann R, Cleary P, Cortes D, Ware N (2006) Associations between adherence to guidelines for antipsychotic dose and health status, side effects and patient care experiences. Med Care. 44:827-834.
6. Dickey B, Normand SL, Hermann R, Eisen SV, Cortes DE, Cleary PD, Ware N (2003) Guidelines recommendations for treatment of schizophrenia: The impact of managed care. Arch Gen Psychiatry. 60:340-348.
7. Donabedian A (2003). An Introduction to Quality Assurance in Health Care. New York: Oxford University Press.
8. Goldman HH, Skodol AE, Lave TR (1992) Revising Axis V for DSM-IV: A review of measures of social functioning. Am J Psychiatry. 149:1148-1156.
9. Greco PJ, Einsenberg JM (1993) Changing physician's practices. N.Engl J Med. 329:1271-1273.
10. Greenberg MD, Pincus HA, Ghinassi FA (2006) Of treatment systems and depression: An overview of quality-improvement opportunities in hospital-based psychiatric care. Harv Rev Psychiatry. 14:195-203.
11. Handley MR, Stuart ME, Kirz HL (1994) An evidence-based approach to evaluating and improving clinical practice: Implementing practice guidelines. HMO Pract. 8:75-82.
12. Hermann RC, Finnerty M, Provost S, Palmer RH, Chan J, Lagodmos G, Teller T, Myrhol BJ (2002) Process measures for the assessment and improvement of quality of care for schizophrenia. Schizophr Bull. 28:95-104.
13. Lehman AF, Steinwachs DM (1998a) Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophr Bull. 24:11-20.
14. Lehman AF, Steinwachs DM (1998b) Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 24:1-10.
15. Lilford RJ, Brown CA, Nicholl J (2007) Use of process measures to monitor the quality of clinical practice. BMJ. 335:648-650.
16. Linden M, Schotte K (2007) A randomized controlled clinical trial comparing "guideline exposed" and "guideline naive" physicians in respect to dosage selection and treatment outcome with doxepin in depressive disorders. Pharmacopsychiatry. 40:77-81.
17. McEvoy JP, Schifler P, Frances A (1999) Treatment of schizophrenia 1999. The expert consensus guidelines series. J Clin Psychiatry. 60:3-80.
18. Guidelines for the treatment of schizophrenia (2002). London: National Institute for Clinical Excellence (NICE).
19. Norcini JJ (2003) Work based assessment. BMJ. 326:753-755.
20. Roberts MJ, Hsiao W, Berman P, Reich MR (2004) Getting Health Reform Right. A Guide to Improving Performance and Equity. New York: Oxford University Press Inc.
21. Rosenheck RA, Desai R, Steinwachs D, Lehman A (2000) Benchmarking treatment of schizophrenia: A comparison of service delivery by the national government and by state and local providers. J Nerv Ment Dis. 188:209-216.
22. West JC, Wilk JE, Olfson M, Rae DS, Marcus S, Narrow WE, Pincus HA, Regier DA (2005) Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice. Psychiatr Serv. 56:283-291.
23. Young AS, Sullivan G, Burnam MA, Brook RH (1998) Measuring the quality of outpatient treatment for schizophrenia. Arch Gen Psychiatry. 55:611-617.